Clincosm LogoSign in Get a demo

Evaluation of Covid 19 Anxiety in Endometriosis Patients

Sponsor
Kanuni Sultan Suleyman Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04337346
Collaborator
(none)
80
Enrollment
1
Location
20
Actual Duration (Days)
121.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

It is aimed to measure the general anxiety and lifestyle information of endometriosis patients about covid 19 pandemic, to evaluate anxiety levels in this period.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    80 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Endometriosis Patients Covid 19 Anxiety
    Actual Study Start Date :
    Apr 5, 2020
    Actual Primary Completion Date :
    Apr 20, 2020
    Actual Study Completion Date :
    Apr 25, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Covid 19 Anxiety levels in Endometriosis Patients [20 days]

      The Beck Anxiety Inventory (BAI); it measures the frequency of anxiety symptoms experienced by the patient. It consists of 21 questions in total. Each item gets an increasing score between 0-3. The total score ranges from 0 - 63. The following guidelines are recommended for the interpretation of scores: 0 -9, normal or no anxiety; 10 -18, mild to moderate anxiety; 19 -29, moderate to severe anxiety; and 30 - 63, severe anxiety.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • endometriosis patients

    • no psychiatric illness

    • no antidepressant use

    Exclusion Criteria:

    • women who had not endometriosis

    • no extra health conditions

    • women younger than 18 and older than 45

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Pinar Yalcin Bahat Istanbul İ̇stanbul Turkey 34000

    Sponsors and Collaborators

    • Kanuni Sultan Suleyman Training and Research Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Pınar Yalcin bahat, Principal Investigator, Kanuni Sultan Suleyman Training and Research Hospital
    ClinicalTrials.gov Identifier:
    NCT04337346
    Other Study ID Numbers:
    • endocovid19
    First Posted:
    Apr 7, 2020
    Last Update Posted:
    May 20, 2020
    Last Verified:
    May 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    COVID-19
    Endometriosis

    Study Results

    No Results Posted as of May 20, 2020